cnbc.com / .cnbc-com-health-care / Page 2

Jim Cramer explained the Investing Club's approach to navigating the market response to the Iran war.

Jim Cramer sees areas to put money to work and places to trim.

Novo Nordisk is investing in a facility in Ireland as it expands its production capacities of the newly launched Wegovy pill, the Danish drugmaker said Monday.

The outlooks of Life Time and Planet Fitness show the divergence in spending between higher- and lower-income consumers.

Jim Cramer spotlighted the "Fourth Industrial Revolution" winners in the Club's portfolio during Friday's Monthly Meeting.

The Bullpen is our watchlist of stocks that we want to consider buying for Jim Cramer's Charitable Trust.

Democrats once counted many of the health-conscious followers of Robert F. Kennedy Jr. among their own ranks.

Novartis and Genentech are suing a U.S. company and a Canadian pharmacy over the importation of a Canadian version of their allergy medicine.

The Danish drugmaker released late-stage data showing that the upcoming injection CagriSema failed to match the weight loss of Eli Lilly's Zepbound.

The cuts aim to make the drugs more accessible to insured patients, particularly people with high-deductible health plans or co-insurance benefit designs.